Categories: News

CoNextions® Inc. Announces Daniel Gruppo as President and Chief Executive Officer

Salt Lake City, Utah, June 27, 2022 (GLOBE NEWSWIRE) — CoNextions® Inc. Announces Daniel Gruppo as President and Chief Executive Officer

Salt Lake City, Utah—CoNextions Inc. (www.conextionsmed.com), an innovator in tendon repair, announced today that Daniel Gruppo has been named as President and Chief Executive Officer effective immediately. Jeff Barnes, who has served as Chief Executive Officer since May of 2017 will continue as Executive Chairman of the Board of Directors.

Gruppo has more than 14 years of senior management experience, including strategic plan development and execution at Stryker. Prior to joining CoNextions in 2016, Mr. Gruppo served as Vice President of Sales and Marketing at Stryker Trauma and Extremities.

“Dan’s management experience at Stryker, coupled with his sales and marketing acumen, make him well suited to assume this role,” said Jeff Barnes, Executive Chairman of the Board. “Erik Kubiak, MD, founder and board member of CoNextions, and I are confident that Dan can make CoNextions the company we envision.”

“I am very excited to be taking on the role of President and CEO of CoNextions and to lead the dedicatied and talented team there,” said Dan Gruppo. “I believe that as we go to market with CoNextions TR™ Tendon Repair System, CoNextions and its surgeon partners and customers will truly revolutionize tendon repair. The early surgeon feedback has me more excited than ever for the future of CoNextions.”

CoNextions Medical is currently launching the CoNextions TR Tendon Repair System throughout the United States and select countries in the global market. The device is marketed by a network of orthopedic distributors focused on hand, wrist, and forearm surgery.

About CoNextions Inc.

Founded in 2011, CoNextions Inc. is a privately held company located in Salt Lake City, Utah. They are an innovation-based medical device company dedicated to achieving safer, stronger, and more durable tendon repairs worldwide marked by faster rehabilitation, fewer complications, and lower long-term costs. For additional information about CoNextions, please contact Dan Gruppo, President and Chief Executive Officer, (385) 645-8380 or at dgruppo@conextionsmed.com.

CONTACT: dgruppo@conextionsmed.com
(385) 645-8380

Staff

Recent Posts

Unique Treatment for BPH, Chronic Prostatitis, Back Pain and Kidney Stones Was Unveiled at Arab Health 2024 by Ariana Adjani

* Efficacy, safety, and cost-effectiveness of Thermobalancing therapy and Dr Allen's Devices were showcased at…

19 hours ago

Financière de Tubize – Annual report 2023

FINANCIERE DE TUBIZE SA/NV Allée de la Recherche 60, 1070 Brussels Contact: investorrelations@financiere-tubize.be Annual Report…

2 days ago

ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call

PLEASANTON, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP…

2 days ago

Ibogaine By David Dardashti Leverages Albert Einstein’s Corelation Between Photon Particles and Quantum Electrodynamics

Ibogaine By David Dardashti Revolutionizes Solar Energy Efficiency Through Radiation Generators Einstein A young and…

2 days ago

Psyence Biomedical Ltd. Receives Nasdaq Notifications Regarding Market Value of Listed Securities and Market Value of Publicly Held Shares

NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (the “Company”) (Nasdaq: PBM)…

2 days ago

NurExone’s Strategic Update: Submission of OTCQB Listing Application to Initiate US financial presence

TORONTO and HAIFA, Israel, March 15, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX)…

2 days ago